Meet the 15 Startups Joining Cure’s Middle East Health Accelerator

Digital health. Remote diagnostics. AI-driven clinical tools. These are just a few of the focus areas of the 15 pioneering startups that have been selected to join the inaugural Cure by Deerfield Middle East Health Accelerator in Qatar— a program designed to support early-stage ventures in the Middle East and North Africa (MENA) region and globally through hands-on guidance and expert mentorship. Each company selected addresses critical healthcare challenges through medtech and next-generation care models. Read the full press release here.

“These 15 startups reflect the depth of global talent driving the future of healthcare. They represent the bold, purpose-driven innovation Cure was founded to advance from concepts to cures,” said Seema Kumar, CEO of Cure. “Through the Cure by Deerfield Middle East Health Accelerator, we are giving founders the tools, mentorship, networks and investor access to transform their promising ventures into scalable, real-world health solutions that could improve lives around the world.”

Launched through a collaboration with Deerfield Management Company (an affiliate of Cure) and the Qatar Investment Authority (QIA), and supported by the Qatar Development Bank (QDB), the 12-week hybrid accelerator will kick off at Cure’s flagship event, The X Factor: Healthcare Innovation Summit on November 11, 2025. The program will offer founders immersive training in valuation, fundraising, go-to-market strategy, and negotiation.

“By bridging the strengths of the U.S. and MENA innovation ecosystems, we’re cultivating a new generation of healthcare companies ready to expand internationally,” said James Flynn, Managing Partner at Deerfield. “In partnership with QIA, we hope to improve the success rate of promising new healthcare products and services to the benefit of innovators, healthcare providers, and patients.”

“Qatar Development Bank is committed to advancing ventures that deliver real impact, and this initiative reflects that vision,” said Mohammed Al-Emadi, QDB’s Executive Director of Incubation and Venture Capital Investment. “The Cure by Deerfield Middle East Health Accelerator will bring world-class healthcare startups to Qatar and equip them with the resources and connections they need to thrive and scale successfully. By engaging directly in this program, we are reinforcing Qatar’s role as a regional launchpad for innovation and enabling healthcare solutions that can improve lives across the region and beyond.”

A Robust Application Pool

Dr. Mussaad M. Al-Razouki, Operating Partner at Deerfield and Accelerator Director, noted that the judging committee received more than 100 applications within a three-week submission period. “The robust application pool reflects an incredible appetite for healthcare innovation across the Middle East and beyond. The 15 companies selected for the inaugural cohort stood out for pairing strong clinical or operational validation with the potential to scale globally and pilot their technologies in Qatar’s health ecosystem with the aim to expand their operations across the Middle East.”

Opportunities to pilot innovations within Qatar’s healthcare system will give participants the tools and exposure they need to bring their transformative solutions to market. This first-of-its-kind program will showcase Qatar’s role as a launchpad for innovative healthcare solutions that will improve lives across MENA and globally.

Here is a closer look at the 15 startups joining the program.

Adam (KSA): Digital clinic specializing in men's sexual and reproductive health.

Arbor Bio (USA/Qatar): RNA-based therapeutics for rare diseases.

Atomistic Insights (USA): AI-powered drug discovery with molecular simulations that predict protein dynamics for biopharma.

Bionl (USA/Qatar): AI-powered workspace for biomedical research.

Ciba Health (USA): AI-powered precision care platform that treats root causes to prevent and reverse chronic disease.

Cure Bionics (Tunisia): 3D-printed, affordable bionic prosthetics for limb differences.

DoriNano (USA): Programmable nanoparticle delivery (DNA-origami) powering oncology and partnered pipelines.

EndoMD Health (USA): Digital-first endocrinology platform delivering in-network care for kids and young adults with metabolic conditions.

HealthOrbit AI (UK): Clinical AI platform for healthcare delivery with ambient scribe, smart voice agent, and revenue assistant.

Luminary Therapeutics (USA/Spain): Next-gen CAR-T cell therapies for cancer treatment.

Medwise.ai (UK): AI clinical search that delivers trusted, evidence-based answers at the point of care.

Periwinkle Technologies (India): AI-enabled cervical screening device that brings single-visit detection into the neighborhood clinic.

Pinecone Therapeutics (USA): Gene therapy program targeting propionic acidemia (PA), a rare metabolic disorder.

Valeo Health (UAE): At-home wellness and health platform focusing on personalized care.

VentriNaya (USA): Biotech advancing heart regeneration with cell therapy, gene therapy, and RNA/peptide medicines.

Read more about how the Middle East Health Accelerator can serve as a launchpad for trailblazing life sciences startups in our interview with Accelerator Director Dr. Mussaad M. Al-Razouki.